March 24, 2026

GoodRx Holdings, Inc. (GDRX): Investor Outlook Reveals 35% Potential Upside Amid Healthcare Tech Evolution

GoodRx Holdings, Inc. (NASDAQ: GDRX), a prominent player in the Health Information Services industry, continues to make waves in the healthcare sector with its innovative offerings..

Healthcare Services Group, Inc. (HCSG) Stock Analysis: Exploring a 22.89% Potential Upside

Healthcare Services Group, Inc. (NASDAQ: HCSG) finds itself at a crossroads with a potential upside of 22.89%, sparking curiosity among investors eager for growth opportunities in..

Pediatrix Medical Group, Inc. (MD) Stock Analysis: Unlocking Value with a Forward P/E of 8.86

Pediatrix Medical Group, Inc. (NYSE: MD), a leading provider in the healthcare sector, particularly in the medical care facilities industry, offers a compelling investment opportunity with..

Pulse Biosciences, Inc. (PLSE) Stock Analysis: Exploring a 43% Potential Upside in the Healthcare Sector

Pulse Biosciences, Inc. (NASDAQ: PLSE) has emerged as a noteworthy player in the medical instruments and supplies industry, with a focus on pioneering bioelectric medicine. As..

NeoGenomics, Inc. (NEO) Stock Analysis: Exploring an 82.87% Potential Upside

NeoGenomics, Inc. (NASDAQ: NEO), a leading player in the diagnostics and research industry, offers investors an intriguing opportunity with a striking potential upside of 82.87%. Operating..

10x Genomics, Inc. (TXG) Stock Analysis: Navigating Growth with a 5.24% Potential Upside

10x Genomics, Inc. (NASDAQ: TXG) stands at the forefront of innovation in the health information services industry. With its cutting-edge platforms and technologies for analyzing biological..

Harrow, Inc. (HROW) Stock Analysis: A 103.68% Potential Upside in the Specialty Pharma Sector

Harrow, Inc. (NASDAQ: HROW), a key player in the healthcare sector, has been making waves with its focus on ophthalmic pharmaceutical products. With a market cap..

Wave Life Sciences Ltd. (WVE) Stock Analysis: Exploring a 193% Potential Upside

Wave Life Sciences Ltd. (NASDAQ: WVE), a clinical-stage biotechnology company headquartered in Singapore, is generating significant buzz among investors with its promising pipeline and substantial potential..

Astrana Health Inc. (ASTH) Stock Analysis: 51% Potential Upside Beckons Investors

Astrana Health Inc. (NASDAQ: ASTH) presents a compelling opportunity for investors in the healthcare sector, particularly those keen on medical care facilities. With a market capitalization..

Progyny, Inc. (PGNY) Stock Analysis: 52.44% Potential Upside in the Fertility Benefits Space

Progyny, Inc. (NASDAQ: PGNY) is making waves in the healthcare sector with its innovative approach to fertility and family-building benefit solutions. With a market capitalization of..

AtriCure, Inc. (ATRC) Stock Analysis: Unpacking a 65.80% Potential Upside

AtriCure, Inc. (NASDAQ: ATRC), a prominent player in the healthcare sector, particularly within the medical instruments and supplies industry, presents an intriguing case for investors seeking..

Schrodinger, Inc. (SDGR) Stock Analysis: Exploring a 94% Potential Upside in Health Information Services

Schrodinger, Inc. (NASDAQ: SDGR), a key player in the healthcare sector, operates within the health information services industry with a unique approach that marries technology and..

Recursion Pharmaceuticals, Inc. (RXRX) Stock Analysis: Unlocking Potential with 107.87% Upside

Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX), a dynamic player in the biotechnology sector, has been turning heads with its ambitious approach to drug discovery. While the current..

Surgery Partners, Inc. (SGRY) Stock Analysis: Exploring a 61% Potential Upside in the Healthcare Sector

Surgery Partners, Inc. (SGRY), a prominent player in the healthcare sector, has caught the attention of investors with its intriguing potential upside of 61.44%, according to..

Ocular Therapeutix, Inc. (OCUL) Stock Analysis: Analyst Ratings Point to a Potential 223% Upside

Investors eyeing opportunities in the biotechnology sector might find Ocular Therapeutix, Inc. (NASDAQ: OCUL) an intriguing prospect, particularly given its compelling analyst ratings and potential upside...

IDEAYA Biosciences, Inc. (IDYA) Stock Analysis: Aiming for a 58% Upside with Innovative Oncology Solutions

IDEAYA Biosciences, Inc. (NASDAQ: IDYA) stands at the forefront of precision medicine in oncology, captivating investor interest with a potential upside of 58.03% based on current..

Concentra Group Holdings (CON) Stock Analysis: A 29.64% Potential Upside Beckons Healthcare Investors

As investors continue to search for compelling opportunities in the healthcare sector, Concentra Group Holdings Parent (CON) stands out with a remarkable potential upside of 29.64%,..

QuidelOrtho Corporation (QDEL) Stock Analysis: Unveiling a Potential 109% Upside in the Healthcare Sector

QuidelOrtho Corporation (QDEL), a prominent player in the healthcare sector, is making waves with its diagnostic testing solutions spread across its diversified business units. With a..

Guardian Pharmacy Services, Inc (GRDN) Stock Analysis: Navigating Growth with a 17.4% Revenue Surge

Guardian Pharmacy Services, Inc. (GRDN) is carving a niche in the healthcare sector with its innovative approach to serving long-term care facilities (LTCFs) in the United..

Establishment Labs Holdings Inc (ESTA): Growth Potential and Investor Sentiment Amidst a 49.3% Upside

Establishment Labs Holdings Inc (NASDAQ: ESTA) is capturing investor attention with a substantial potential upside of 49.3%, according to analysts. The company, a key player in..

Search

Funds

March 24, 2026

Search

Funds

March 24, 2026

FTSE 100

Funds